Jonathan Buggey is a Cardiology physician affiliated with Summa Health System. OpenAlex indexes 15 publications with 289 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingIndustry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
1 company with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
80%Beta blocker17.9%Metoprolol Succinate51%Carvedilol45%Metoprolol Tartrate4%Part D≥128 patientsLoop diuretic13.3%Torsemide56%Furosemide39%Bumetanide5%Part D<11 patients+ 16 more classes in this area
Blood & clotting
9.2%Factor Xa inhibitor7.7%Eliquis93%Xarelto7%Part D≥87 patientsP2Y12 inhibitor1.2%Clopidogrel78%Brilinta22%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
8.5%SGLT2 inhibitor6.9%Farxiga61%Jardiance39%Part D≥54 patientsPotassium supplement1%Potassium Chloride100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- ARRHYTHMOGENIC GENOTYPE-NEGATIVE CARDIOMYOPATHY: IS CARDIAC MRI PHENOTYPE ENOUGH FOR A DIAGNOSIS?
Journal of the American College of Cardiology
2025 - PREVALENCE AND SIGNIFICANCE OF PULMONARY HYPERTENSION IN PATIENTS WITH CARDIAC AMYLOIDOSIS
Journal of the American College of Cardiology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Thomas File, MD
Summa Health System
Marc Penn, MD
Summa Health System
Drazen Petrinec, MD
Summa Health System
Sameer Mahesh, MD
Summa Health System
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”